Sumitomo Life Insurance CO Incyte Corp Transaction History

Sumitomo Life Insurance CO

  • $5.28 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Jul 23, 2018
SELL
$60.85 - $83.98 $907,699 - $1.25 Million
-14,917 Closed
0 $0
Q1 2018

Apr 27, 2018
BUY
$83.06 - $100.98 $436,729 - $530,952
5,258 Added 54.44%
14,917 $1.24 Million
Q4 2017

Feb 01, 2018
SELL
$93.56 - $116.6 $40,605 - $50,604
-434 Reduced 4.3%
9,659 $915,000
Q3 2017

Oct 17, 2017
BUY
$109.15 - $138.27 $1.1 Million - $1.4 Million
10,093
10,093 $1.18 Million

Others Institutions Holding INCY

# of Institutions
657
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Sumitomo Life Insurance CO Portfolio

Follow Sumitomo Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email